Tag: drug

Posted on

Sanofi’s dual-action biotech asthma drug performs well in test – Reuters

Sanofi's dual-action biotech asthma drug performs well in test
Reuters
Nov 11 (Reuters) – An experimental biotech drug for severe asthma from France's Sanofi and its U.S. partner Regeneron has produced good results in clinical tests, suggesting its dual-action mechanism may be highly effective. Dupilumab is a latecomer …
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of …SYS-CON Media (press release)
Regeneron, Sanofi Say Phase 2b trial of Dupilumab Meets Primary EndpointRTT News

all 5 news articles »

View full post on asthma – Google News

Posted on

Newly Developed Vaccines Could Reveal Asthma Clues – Drug Discovery & Development


Drug Discovery & Development

Newly Developed Vaccines Could Reveal Asthma Clues
Drug Discovery & Development
Their potential application to disorders such as asthma has a somewhat different focus. Macrophages that are able to sustain their activation state for prolonged periods might also contribute to chronic lung diseases such as asthma and COPD …
Developing Lifesaving Vaccines in a New WayNewswise (press release)

all 2 news articles »

View full post on asthma – Google News

Posted on

GSK Submits European, US Filings for Asthma Med – Drug Discovery & Development

GSK Submits European, US Filings for Asthma Med
Drug Discovery & Development
GlaxoSmithKline announced that it has filed regulatory submissions in the USA and Europe for mepolizumab for approval as a maintenance treatment for patients with severe eosinophilic asthma, identified by a blood eosinophil count of at least 150 cells …
GSK Files for Approval of Mepolizumab in US, Europe for Eosinophilic AsthmaRTT News
GSK submits asthma biologic in US, EUPharmaTimes
GlaxoSmithKline heads to the FDA with its next big respiratory betFierceBiotech
The Pharma Letter –London South East
all 8 news articles »

View full post on asthma – Google News

Posted on

FDA to review new drug application for Spiriva Respimat for asthma – Healio

FDA to review new drug application for Spiriva Respimat for asthma
Healio
Boehringer Ingelheim Pharmaceuticals announced that the FDA has agreed to review its new drug application for tiotropium bromide inhalation spray for long-term maintenance of patients aged 12 years and older with asthma, according to a press release.
Boehringer Ingelheim Announces U.S. Filing Acceptance of New Drug …PR Newswire (press release)

all 3 news articles »

View full post on asthma – Google News

Posted on

Adverse drug reactions in children following use of asthma medications – Science Codex

Adverse drug reactions in children following use of asthma medications
Science Codex
"We have studied all EU adverse drug reaction reports on asthma medications approved for – and used by – children over a five-year period (2007 to 2011). In the light of the total use of asthma medications, the number of reported ADRs were not …

View full post on asthma – Google News

Posted on

AstraZeneca Gets Positive Results for Asthma Drug – Drug Discovery & Development

AstraZeneca Gets Positive Results for Asthma Drug
Drug Discovery & Development
AstraZeneca announced that The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase 2b study evaluating benralizumab, a novel investigational monoclonal antibody, in patients with severe, uncontrolled asthma and …
AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbusterFierceBiotech
AstraZeneca share price: Novel drug shows positive results for severe asthmaiNVEZZ
AstraZeneca's benralizumab succeeds in severe asthmaPharmaTimes

all 5 news articles »

View full post on asthma – Google News

Posted on

FDA says asthma drug Xolair raises risk of heart, brain problems – MSN Philippines News

FDA says asthma drug Xolair raises risk of heart, brain problems
MSN Philippines News
WASHINGTON – The asthma drug Xolair is associated with a higher risk of heart attack, mini-stroke, chest pain and blood clots in the lungs and veins, among other problems, though the extent of increased risk is unclear, the U.S. Food and Drug …

and more »

View full post on asthma – Google News